PedAM
Pediatric Disease Annotations & Medicines
| Disease | osteogenesis imperfecta |
| Phenotype | C0027051|myocardial infarction |
| Sentences | 1 |
| PubMedID- 23226945 | Currently, autologous mscs derived from bone marrow have been applied for cell-based therapies, including the treatment of osteogenesis imperfecta, intracoronary transplantation in patients with acute myocardial infarction, and support of haematopoiesis [50, 51, 53, 54, 56]. |
Page: 1